Students & Alumni
Alaina Adamos
CRC, Stanford
Jennifer Bachand
PEDs Fellow, Stanford
Yi Lu
5Y Capital, HK
Kyle Chen, PhD, JD, MBA
Greenberg Traurig LLP
Yue (Ami) Chen
Univ of Edinburgh, UK
Naomi Choi, DPM, MBA
Chief Resident, Yale
Jerry Cromarty
QA Manager, ImpriMed
Elena De Loizaga
CRC, Stanford
Philip Fernandes, MD
PEDS Fellow, Stanford
Veronica Gutierrez
Business Development Analyst at Saya Biologics
Elsa Harte, MBBS
Physician, UK
Huang Huang, MBA
Associate, Foxbridge Capital
Daniel Rey Jimenez
Cofounder, BioLynx
Jasmine Jing
CMO, TechInu Inc.
Samuel Kim
MD’28, Univ of Missouri
Joyce Kwan
Sr Res Assoc, Anwita Bio
Jacquelyn Lai
Researcher, PAVIR
Kelly Grace Lee
UC Berkeley ‘26
Samuel Leong
Legal Intern, Allen & Gledhill LLP
Alvin Liong
CPO, NCCS, Singapore
Julia Nguyen
UC San Diego ‘26
Nour Omar
PhD ‘29, Stanford Neuro
Parsa Parirokh
Scientist, Arcturus Tx
Diya Patel
BD Assocate, DigPath
Santiago Plata Salazar
BD Associate, Tenomics
Karenah Rajasekaran
R&D Scientist, Regenere
Keyuree Satam, MD, MS
Resident, Stanford Surgery
Ritvij Singh, MBBS
Consultant, BCG
Julien Stroumzv
MD’28, Loyola Univ
Ariel (Yan Qiu) Wang
Medical Assistant, UCLA
Sean Yeung
LSRP, Stanford
Shirly Zhang
Analyst, Lazard Health
News About M-TRAM Students and Alumni
Rahul Penumaka awarded the prestigious Knight-Hennessy Scholarship (KHS) to study at M-TRAM. The program is considered one of the most prestigious and competitive scholarships in the world. In 2024, 90 scholars were selected from a pool of 8,272 applicants for a selection rate of 1.09%.
Rahul Penumaka (M-TRAM 2024/25)
Massive congratulations to HLA Scholar Ifan Jenkin for receiving the Fulbright All Disciplines Postgraduate Award for a Master's of Science in Translational Research and Applied Medicine at Stanford University!
Ifan Jenkin (M-TRAM 2024/25)
Frank Lin, MS, M-TRAM Graduate '23, contributes to breakthrough cancer treatment research: his M-TRAM Capstone Project mentored by Professor Crystal Mackall culminates in high-impact Nature paper.
The study, which was a culmination of Frank's capstone research for M-TRAM, demonstrated a novel approach to cancer therapy by combining antibodies with T cells. By engineering a variant of the CD47 protein, which usually signals immune cells not to attack healthy tissue, researchers enhanced the immune system's ability to target cancer cells. This breakthrough could pave the way for more effective cancer treatments, leveraging the body's own defenses to combat tumors with greater precision and potency.
Wolf Earns M-TRAM Master’s Degree | Mahajan Laboratories
Palo Alto, CA — Julian Wolf M.D., postdoctoral fellow in the Mahajan Lab, graduated with the first class of Stanford’s Master of Science in Translational Research and Applied Medicine (M-TRAM) Program. Nobel Laureate and Stanford Professor Carolyn Bertozzi Ph.D. gave the keynote and her congratulations to Julian. The aim of the M-TRAM Program is to give graduates the tools to
'Disease accelerates aging': Stanford researchers develop an AI-driven aging clock for eyes
Using eye fluid samples from liquid biopsies, Stanford researchers created a protein-cell map connecting 6,000 eye proteins back to their cellular origins, 26 of which were incorporated into an AI model to predict a patient’s age.
Important Dates
Interested in Becoming an M-TRAM Industry Partner?
We welcome inquiries from biotechnology, pharmaceutical and other health care organizations interested in learning about opportunities to partner with M-TRAM: